{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibjhpknpwghkk4oqijy6ug6v722qedix4rlgm2sntmlaydddsozb4",
    "uri": "at://did:plc:gpye7rjvvd4zety5zn7xb2x5/app.bsky.feed.post/3mizi3oivcsr2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvbwpquesgzl4bhcjmpuysltsosbm46slkupsrz773wciahowpui"
    },
    "mimeType": "image/jpeg",
    "size": 112609
  },
  "path": "/johns-hopkins-team-develops-therapeutic-nasally-delivered-dna-vaccine-for-tuberculosis/",
  "publishedAt": "2026-04-08T18:30:52.000Z",
  "site": "https://www.goodnewsnetwork.org",
  "tags": [
    "Science",
    "Disease",
    "Treatment",
    "Vaccine",
    "Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis",
    "Good News Network"
  ],
  "textContent": "A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world’s leading cause of death from infectious disease. The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial survivors that can endure antibiotic treatment to spread another day. The paper on the […]\n\nThe post Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis appeared first on Good News Network.",
  "title": "Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis"
}